Correction: Characterization of chimeric antigen receptor modified T cells expressing scFv-IL-13Rα2 after radiolabeling with 89Zirconium oxine for PET imaging

• Pamela Leland,
• Dhiraj Kumar,
• Sridhar Nimmagadda,
• Steven R. Bauer,
• Raj K. Puri,
• Bharat H. Joshi

Affiliations

Pamela Leland

Tumor Vaccines and Biotechnology Branch, Division of Cellular and Gene Therapies, Office of Tissues and Advance Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration

Dhiraj Kumar

Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine

Sridhar Nimmagadda

Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine

Steven R. Bauer

Tumor Vaccines and Biotechnology Branch, Division of Cellular and Gene Therapies, Office of Tissues and Advance Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration

Raj K. Puri

Tumor Vaccines and Biotechnology Branch, Division of Cellular and Gene Therapies, Office of Tissues and Advance Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration

Bharat H. Joshi

Tumor Vaccines and Biotechnology Branch, Division of Cellular and Gene Therapies, Office of Tissues and Advance Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration